Bal Pharma Share Price

Bal Pharma Share Price

NSE: BALPHARMA
|
Pharmaceuticals

₹ 99.50

+₹0.11 (0.11%)
1D
Last updated 14 Oct, 2026, 13:45 IST

Bal Pharma Share Price Today

As of 14 Oct 2026, Bal Pharma share price is ₹99.50. The stock opened at ₹99.38, compared to its previous close of ₹99.39. During today's trading session, Bal Pharma share price moved in the range of ₹96.18 to ₹101.99, with an average price of ₹99.09 for the day. Looking at its last 52-week, the stock has touched a low of ₹60.00 and a high of ₹124.60. On the performance front, Bal Pharma share price has increased by 32.20% over the last six months and is up 21.06% on a year-on-year basis.

₹96.18
0.11% up today
₹101.99
1D LOW
1D HIGH

Bal Pharma Returns Calculator

Volume
2,664
Average traded price
₹99.60
Last traded time
01:45:54 14 Oct
Last traded quantity
10
Circuit
L
H
₹94.43
₹104.35
52-week
L
H
₹60.00
₹124.60
Mkt Cap Cr
155.71
P/E
21.76
P/B
1.92
ROA
1.93%
ROE
7.64%
ROCE
9.18%
Quick Ratio
0.59
EV/EBITDA
8.69
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Bal Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Bal Pharma appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Bal Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0135.035.0811.19%13.74%17.33%2.3121.42
Divis Laboratories2,46,222.1184.1814.6914.6%15.32%19.56%3.556.81
Torrent Pharmaceuticals1,76,300.5081.7720.964.87%25.49%13.85%0.7538.3
Zydus Lifesciences1,12,817.6824.574.168.57%18.59%17.35%0.9115.07
Laurus Labs1,11,898.66101.6420.9110.38%16.77%16.14%0.6854.71
Cipla1,06,129.9632.023.127.92%11.27%14.95%2.517.97
Dr. Reddy's Laboratories1,03,471.1432.52.725.48%11.07%12.54%1.3516.27
Mankind Pharma99,089.5247.326.07.36%11.74%13.13%0.7426.02
Aurobindo Pharma96,836.1026.12.566.34%9.25%11.76%1.1512.57
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.46

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Bal Pharma

Bal Pharma Share Price
ISIN
INE083D01012
Sector Market Cap
₹ 155.71 Cr

Bal Pharma Limited is a pharmaceutical company engaged in the manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It specializes in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers a range of APIs including antihistamine, platelet inhibitor, anti-diabetic, anticonvulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers a range of formulations covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmics, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.

Bal Pharma Financial Highlights

  • Revenue: Bal Pharma reported revenue of ₹313.59 crore in FY26 vs ₹305.28 crore in FY25. It showed an increase of 2.72% on a yearly basis.
  • Operating Profit: Bal Pharma reported an operating profit of ₹5.93 crore in FY26 vs ₹5.14 crore in FY25. It showed an increase of 15.37% on a year-on-year basis.
  • Net Profit: Bal Pharma reported a net profit of ₹6.32 crore in FY26 vs ₹7.24 crore in FY25. It showed a decrease of 12.71% on a yearly basis.

Bal Pharma Quarterly Result Highlights

  • Bal Pharma reported revenue of ₹89.06 crore in Jun 2026, compared with ₹83.84 crore in Mar 2026, representing an increase of 6.23% on a quarter-on-quarter (QoQ) basis.
  • Bal Pharma reported an operating profit of ₹1.14 crore in Jun 2026, compared with ₹3.22 crore in Mar 2026, representing a decrease of 64.60% on a quarter-on-quarter (QoQ) basis.
  • Bal Pharma reported a profit of ₹1.14 crore in Jun 2026, compared with ₹3.60 crore in Mar 2026, reflecting a decrease of 68.33% on a QoQ basis.
  • The earnings per share (EPS) of Bal Pharma stood at ₹3.95 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
50.86%
FII
0.28%
Other DII
0.00%
Retail and other
48.87%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.14%
Mar 20260.14%
Jun 20260.15%
Sep 20260.28%
1 day
+1.72%
1 week
-2.04%
1 month
-7.48%
1 year
+21.06%
3 years
+7.45%
5 years
-5.84%
Day
Open / Close
Change %
13 Oct 26
₹101.20 / ₹99.39
+1.72%
12 Oct 26
₹93.06 / ₹97.71
+5.00%
09 Oct 26
₹94.29 / ₹93.06
-3.27%
08 Oct 26
₹100.59 / ₹96.21
-2.44%
Show more

Bal Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹311.66₹303.08₹339.22₹304.22
Other Income₹1.93₹2.20₹2.85₹0.94
Total Revenue₹313.59₹305.29₹342.07₹305.16
Total Expenses₹307.66₹300.15₹333.02₹300.41
Profit Before Tax₹5.93₹5.14₹9.05₹4.75
Tax-₹0.39-₹2.10₹1.60₹2.13
Profit After Tax₹6.32₹7.24₹7.45₹2.62
EPS - Basic₹3.95₹4.56₹4.96₹1.67
EPS - Diluted₹3.95₹4.56₹4.96₹1.68

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.93₹5.14₹9.05₹4.75
Income before WC changes₹32.47₹29.88₹31.39₹26.49
Change in Assets-₹29.37-₹11.84-₹3.06-₹65.63
Change in Liabilities₹27.73₹4.35-₹0.98₹38.11
Change in WC-₹1.64-₹7.49-₹4.04-₹27.53
Cash flow from Operations₹30.84₹20.31₹22.81-₹1.54
Cash flow from Investing-₹20.70-₹14.92-₹18.89-₹22.18
Cash flow from Financing-₹9.59-₹7.84-₹1.21₹24.09
Total Cash Flow₹0.55-₹2.44₹2.71₹0.37
Cash (Start of the year)₹1.75₹4.20₹1.49₹1.11
Cash (End of the year)₹2.30₹1.75₹4.20₹1.49

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹113.31₹100.82₹85.68₹85.02
Current Assets₹262.23₹234.87₹234.16₹228.16
Total Assets₹375.54₹335.69₹319.84₹313.17
Current Liabilities₹249.23₹219.50₹203.06₹209.33
Net Current Asset₹13.01₹15.37₹31.10₹18.82
Non-Current Liabilities₹44.06₹38.79₹44.81₹40.14
Equity Capital₹82.25₹77.40₹71.97₹63.70
Total Equity & Liabilities₹375.54₹335.69₹319.84₹313.17

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹310.80₹302.50₹338.54₹303.10
Other Income₹2.00₹2.15₹2.30₹2.19
Total Revenue₹312.80₹304.65₹340.84₹305.29
Total Expenses₹306.43₹298.91₹331.52₹296.74
Profit Before Tax₹6.37₹5.73₹9.32₹8.55
Tax-₹0.39-₹2.07₹1.59₹2.42
Profit After Tax₹6.75₹7.80₹7.73₹6.13
EPS - Basic₹4.51₹4.89₹5.13₹3.90
EPS - Diluted₹4.51₹4.89₹5.13₹3.94

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6.37₹5.73₹9.32₹8.55
Income before WC changes₹32.88₹30.34₹30.85₹27.40
Change in Assets-₹29.66-₹12.58₹2.56-₹42.56
Change in Liabilities₹27.61₹4.63-₹0.32₹21.04
Change in WC-₹2.04-₹7.95₹2.23-₹21.52
Cash flow from Operations₹30.83₹20.31₹28.54₹5.38
Cash flow from Investing-₹20.69-₹14.90-₹18.84-₹22.08
Cash flow from Financing-₹9.58-₹7.83-₹6.94₹17.12
Total Cash Flow₹0.56-₹2.42₹2.76₹0.42
Cash (Start of the year)₹1.64₹4.06₹1.30₹0.81
Cash (End of the year)₹2.19₹1.64₹4.06₹1.23

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹115.42₹102.91₹87.68₹77.75
Current Assets₹275.64₹247.65₹246.55₹269.95
Total Assets₹391.06₹350.56₹334.23₹347.70
Current Liabilities₹243.30₹213.46₹197.13₹212.15
Net Current Asset₹32.33₹34.19₹49.41₹57.80
Non-Current Liabilities₹43.65₹38.28₹44.25₹39.52
Equity Capital₹104.10₹98.82₹92.84₹96.03
Total Equity & Liabilities₹391.06₹350.56₹334.23₹347.70
* All values are in INR Crore
Qty
Bid
39
97.01
200
97
50
96.52
50
96.5
50
96.25
Ask
Qty
99.98
360
99.99
50
101.38
100
101.49
25
101.5
40
Bid Total: 389
Ask Total: 575
Buy orders: 40%
Sell orders: 60%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.17
Neutral
ATR (14)
5.89
Neutral
STOCH(9,6)
34.16
Neutral
STOCH RSI (14)
34.23
Neutral
ADX(9)
25.87
Bearish
UO(9)
40.43
Neutral
ROC(12)
-5.36
Bearish
WillR(14)
-67.73
Neutral
Period
Simple value
Exponential vaue
5D
97
98.5
10D
102.06
100.3
20D
103.79
100.86
50D
95.22
96.75
100D
90.41
91.14
Volume trend — traded volume by day
14 Oct0L
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Bal Pharma Share Price
Bal Pharma
Pharmaceuticals
Add Stock
Add Another

Bal Pharma Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.